Thank you. Good morning, everyone. Thank you for joining us for Haemonetics third quarter fiscal '21 conference call and webcast. I'm joined today by Chris Simon, our CEO; Stewart Strong, President of the Hospital Business Unit; and Bill Burke, our CFO. This morning, we posted our third quarter and year-to-date fiscal ' 21 results to our Investor Relations website, including the analytical tables with the information that we'll refer to on this call, and an investor presentation on the pending Cardiva transaction. Additionally, we provided a complete P&L, balance sheet, summary statement of cash flows, as well as reconciliations of our GAAP to non-GAAP adjusted results. Before we get started, unless noted otherwise, all revenue growth rates discussed today are on an organic basis and exclude the impacts of currency fluctuation, strategic exits of product lines, acquisitions and divestitures.